Repare Therapeutics Statistics

Total Valuation

RPTX has a market cap or net worth of $148.56 million. The enterprise value is -$57.39 million.

Market Cap	148.56M
Enterprise Value	-57.39M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

RPTX has 42.45 million shares outstanding. The number of shares has increased by 0.51% in one year.

Shares Outstanding	42.45M
Shares Change (YoY)	+0.51%
Shares Change (QoQ)	-3.59%
Owned by Insiders (%)	0.99%
Owned by Institutions (%)	36.43%
Float	20.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.15
Forward PS	8.75
PB Ratio	0.73
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.27, with a Debt / Equity ratio of 0.01.

Current Ratio	7.27
Quick Ratio	7.08
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.52% and return on invested capital (ROIC) is -26.27%.

Return on Equity (ROE)	-30.52%
Return on Assets (ROA)	-22.30%
Return on Capital (ROIC)	-26.27%
Revenue Per Employee	$383,704
Profits Per Employee	-$382,799
Employee Count	179
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

Income Tax	-15.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.16% in the last 52 weeks. The beta is 0.70, so RPTX's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	-72.16%
50-Day Moving Average	3.27
200-Day Moving Average	4.63
Relative Strength Index (RSI)	62.31
Average Volume (20 Days)	99,938

Short Selling Information

The latest short interest is 721,297, so 1.70% of the outstanding shares have been sold short.

Short Interest	721,297
Short Previous Month	741,690
Short % of Shares Out	1.70%
Short % of Float	3.59%
Short Ratio (days to cover)	8.08

Income Statement

In the last 12 months, RPTX had revenue of $68.68 million and -$68.52 million in losses. Loss per share was -$1.62.

Revenue	68.68M
Gross Profit	-59.95M
Operating Income	-95.79M
Pretax Income	-83.68M
Net Income	-68.52M
EBITDA	-93.80M
EBIT	-95.79M
Loss Per Share	-$1.62

Full Income Statement

Balance Sheet

The company has $208.12 million in cash and $2.18 million in debt, giving a net cash position of $205.95 million or $4.85 per share.

Cash & Cash Equivalents	208.12M
Total Debt	2.18M
Net Cash	205.95M
Net Cash Per Share	$4.85
Equity (Book Value)	203.68M
Book Value Per Share	4.80
Working Capital	197.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$79.61 million and capital expenditures -$398,000, giving a free cash flow of -$80.01 million.

Operating Cash Flow	-79.61M
Capital Expenditures	-398,000
Free Cash Flow	-80.01M
FCF Per Share	-$1.88

Full Cash Flow Statement

Margins

Gross margin is -87.28%, with operating and profit margins of -139.46% and -99.76%.

Gross Margin	-87.28%
Operating Margin	-139.46%
Pretax Margin	-121.83%
Profit Margin	-99.76%
EBITDA Margin	-136.56%
EBIT Margin	-139.46%
FCF Margin	-116.49%

Dividends & Yields

RPTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.51%
Shareholder Yield	-0.51%
Earnings Yield	-46.12%
FCF Yield	-53.85%

Analyst Forecast

The average price target for RPTX is $17.33, which is 395.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.33
Price Target Difference	395.14%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	12.03%
EPS Growth Forecast (5Y)	-18.57%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RPTX has an Altman Z-Score of 3.01 and a Piotroski F-Score of 1.

Altman Z-Score	3.01
Piotroski F-Score	1